Galectin Therapeutics Overview
Galectin Therapeutics Discounted Cash Flow
DCF Analysis for GALT.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.82
Current Fair Value
$-1.82
↓ 169.3% Downside
Overvalued by 169.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison